Stock TTOO T2 BIOSYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
2.72 USD -13.92% Intraday chart for T2 Biosystems, Inc. -10.23% -56.65%
Apr. 23 Top Premarket Decliners MT
Apr. 01 T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The Company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. It also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.

Number of employees: 113

Sales per Business

USD in Million2022Weight2023Weight Delta
Consumables
67.3 %
8 36.7 % 5 67.3 % -40.84%
Instruments
18.5 %
2 10.3 % 1 18.5 % -42.31%
Service
6.6 %
1 3.1 % 0 6.6 % -31.41%
Contribution
5.9 %
11 49.5 % 0 5.9 % -96.17%
Instrument Rentals
1.7 %
0 0.3 % 0 1.7 % +58.97%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
62.5 %
18 82.5 % 4 62.5 % -75.59%
International
37.5 %
4 17.5 % 3 37.5 % -30.77%

Managers

Managers TitleAgeSince
John Sperzel CEO
 Chief Executive Officer 60 20-01-07
John Sprague DFI
 Director of Finance/CFO 65 18-01-29
Roger Smith CTO
 Chief Tech/Sci/R&D Officer 59 13-12-31
Kelley Morgan HRO
 Human Resources Officer - 14-02-28
Matthew McKillip SAM
 Sales & Marketing - -
Michael Gibbs LAW
 General Counsel 53 14-11-30
Brett Giffin PRN
 Corporate Officer/Principal 66 21-11-07

Members of the board

Members of the board TitleAgeSince
David Elsbree BRD
 Director/Board Member 76 14-06-30
Seymour Liebman BRD
 Director/Board Member 74 16-09-20
Robin Toft BRD
 Director/Board Member 63 20-06-13
John Cumming BRD
 Director/Board Member 78 14-06-30
Ninfa Saunders BRD
 Director/Board Member 72 20-06-13
John Sperzel CEO
 Chief Executive Officer 60 20-01-07
Laura Adams BRD
 Director/Board Member 67 21-10-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,792,950 1,035,151 ( 11.77 %) 0 11.77 %

Shareholders

NameEquities%Valuation
CR Group LP
83.22 %
4,104,838 83.22 % 12 M $
New Dimensions Trading Ltd.
7.096 %
350,000 7.096 % 1 M $
Jacob Safier
7.096 %
350,000 7.096 % 1 M $
Susquehanna Securities LLC
1.115 %
55,004 1.115 % 165 012 $
Vanguard Global Advisers LLC
0.9264 %
45,695 0.9264 % 137 085 $
BlackRock Institutional Trust Co. NA
0.7493 %
36,961 0.7493 % 110 883 $
Geode Capital Management LLC
0.4877 %
24,054 0.4877 % 72 162 $
GSA Capital Partners LLP
0.4171 %
20,572 0.4171 % 61 716 $
Jason Carrick
0.4055 %
20,000 0.4055 % 60 000 $
Jane Street Group LLC
0.3126 %
15,417 0.3126 % 46 251 $
NameEquities%Valuation
CR Group LP
-
10,875 - 32 625 $
NameEquities%Valuation
CR Group LP
28.00 %
280 28.00 % 840 $

Company contact information

T2 Biosystems, Inc.

101 Hartwell Avenue

02421, Lexington

+781 761 4646

http://www.t2biosystems.com
address T2 Biosystems, Inc.(TTOO)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
T2 BIOSYSTEMS, INC. Stock T2 Biosystems, Inc.
-56.65% 27.79M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.35% 209B
DANAHER CORPORATION Stock Danaher Corporation
+9.41% 175B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.75% 131B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+19.34% 99.98B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.84% 61.12B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+15.08% 52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-2.10% 46.5B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.10% 39.24B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.50% 38.47B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. TTOO Stock
  4. Company T2 Biosystems, Inc.